Viral miRNA-mediated activation of hyaluronan production as a drug target against COVID-19

• Shuai Yang,
• Lu Chen,
• Ying Tong,
• Wenqiang Yu

Affiliations

Shuai Yang

Laboratory of RNA Epigenetics, Institutes of Biomedical Sciences & Shanghai Public Health Clinical Center & Department of General Surgery, Huashan Hospital, Cancer Metastasis Institute, Shanghai Medical College, Fudan University, Shanghai 200040, China; Shanghai Key Laboratory of Medical Epigenetics, Shanghai 200032, China

Lu Chen

Laboratory of RNA Epigenetics, Institutes of Biomedical Sciences & Shanghai Public Health Clinical Center & Department of General Surgery, Huashan Hospital, Cancer Metastasis Institute, Shanghai Medical College, Fudan University, Shanghai 200040, China; Shanghai Key Laboratory of Medical Epigenetics, Shanghai 200032, China

Ying Tong

Laboratory of RNA Epigenetics, Institutes of Biomedical Sciences & Shanghai Public Health Clinical Center & Department of General Surgery, Huashan Hospital, Cancer Metastasis Institute, Shanghai Medical College, Fudan University, Shanghai 200040, China; Shanghai Key Laboratory of Medical Epigenetics, Shanghai 200032, China

Wenqiang Yu

Laboratory of RNA Epigenetics, Institutes of Biomedical Sciences & Shanghai Public Health Clinical Center & Department of General Surgery, Huashan Hospital, Cancer Metastasis Institute, Shanghai Medical College, Fudan University, Shanghai 200040, China; Shanghai Key Laboratory of Medical Epigenetics, Shanghai 200032, China; Corresponding author.